# Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

> PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29184433-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-03-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29184433-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29184433-linaclotide-v1.json
- Content SHA-256: `e975b90e3116e99db3a9e093a223813baf9650d3f5a1b33b3d817567239bcc5f`

## Claims and source pins

### Headline

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

### Summary

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

### Paragraph 1

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

## Sources

<a id="source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6"></a>
- **Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. · retained source version 1:2024-03-27:current:f752f49a1ea67ab8c7816615e9f540360698d9f1bf9fd7ea51eaee234991c325** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29184433/) (`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29184433-linaclotide-v1.json SHA-256: e975b90e3116e99db3a9e093a223813baf9650d3f5a1b33b3d817567239bcc5f.